Jay Duker Net Worth & Insider Trades

Jay Duker - President and CEO, Eyepoint Pharmaceuticals, Inc

As of July 12, 2023

What is Jay Duker's Net Worth?

The current estimated net worth of Eyepoint Pharmaceuticals, Inc's President and CEO, Jay Duker, is estimated to be about $331.65K . Jay Duker owns about 17,500 units of Eyepoint Pharmaceuticals, Inc common stock. In the last 5 years at Eyepoint Pharmaceuticals, Inc, Jay Duker has sold an estimated value of $41.57K worth.

What is Jay Duker's Past Insider Trading?

Jay Duker's largest purchase order was 5,000 units , worth over $9.45K on April 3, 2019. In total, Jay Duker has made about 15 transactions over 5 years of their time at Eyepoint Pharmaceuticals, Inc. Jay Duker usually trades in June, with the busiest year in 2019 and 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Price per Share
Filing Date
No matching records found


Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Jay Duker's' Mailing Address?

  • Mailing address is C/o Eleven Biotherapeutics 215 1st St. #400 Cambridge MA 02142 MA

Eyepoint Pharmaceuticals, Inc Executive Compensation

Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Nancy Lurker 2020 $581,957 - $482,460 $563,216 $454,508 $15,660 $2,097,801
Nancy Lurker 2019 $577,037 - $650,207 $693,165 $144,034 $15,340 $2,079,783
George Elston 2020 $440,000 - - $83,104 $236,940 $15,660 $775,704
George Elston 2019 $58,385 $20,000 - $635,555 - $2,068 $716,008
Dario Paggiarino 2020 $436,156 - $158,864 $185,417 $242,371 $15,660 $1,038,468
Dario Paggiarino 2019 $420,862 - - $275,775 $105,188 $15,340 $817,165
Scott Jones 2020 $376,250 - $158,864 $185,417 $212,135 $15,660 $948,326
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1314102/000156459021022639/eypt-def14a_20210622.htm

What are Eyepoint Pharmaceuticals, Inc's Past Insider Trades?

Eyepoint Pharmaceuticals, Inc's most recent insider trade came on September 6, 2023 by Ew Healthcare Partners Lp, Ew Healthcare Partnersa Lp, Essex Woodlands Fund Ixgp Lp and Essex Woodlands Ix Llc who sold 20,000 units worth $197.98K . In the last 5 years, insiders at Eyepoint Pharmaceuticals, Inc have sold an estimated value of $9.08M and bought an estimated value of $22.04M worth of shares. Insider trading is most common in June, with the busiest year in 2023. The most active traders at the company are Nancy Lurker, Executive Vice Chair,  Dario Paggiarino, Chief Medical Officer,  and Jay Duker, President and CEO .

EyePoint Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Price per Share
Filing Date
No matching records found